Literature DB >> 1517566

Locus-specific transcriptional control of HLA genes.

T W Soong1, K M Hui.   

Abstract

One remarkable genetic feature of the class I MHC genes is their unparalleled degree of genetic polymorphism and diversity. The polymorphism is reflected by the fact that multiple loci encode class I molecules, and for each locus there are multiple alleles. In the course of investigating the regulation of HLA-A and HLA-B mRNA in human colorectal carcinoma cell lines, we have noticed a noncoordinate expression of the HLA mRNA in some of these cell lines. This observation prompted us to make use of these cell lines to study the locus-specific transcriptional regulation of HLA genes. Bandshift and footprint assays revealed at least three distinct and independent DNA-binding factors that bind to the core regulatory element of the HLA-A and HLB-B gene locus. A "novel" DNA-binding factor recognizing the CCAAT motif seems to be important for locus-specific expression of HLA-A mRNA, whereas a different factor which binds to a Sp1-like sequence is crucial for normal HLA-B mRNA expression. In certain colorectal cancer cell lines, underrepresentation of these locus-specific DNA-binding proteins correlates with the locus-specific down-regulation of HLA mRNA. This observation is further supported by experiments which demonstrated that the locus-specific suppression of exogenously introduced TK-chloramphenicol acetyltransferase DNA constructs, containing the "putative" HLA locus-specific DNA core regulatory sequence, is regulated in a locus-specific manner when introduced into these HLA-A- and HLA-B-deficient human colorectal cell lines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517566

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  HLA-A and HLA-B transcription decrease with ageing in peripheral blood leucocytes.

Authors:  C Le Morvan; M Cogné; M Drouet
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 2.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Characterization of a novel IRF-1-deficient mutant cell line.

Authors:  S P Lim; K M Hui
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 4.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

5.  Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?

Authors:  A Hamdi; K Cao; L M Poon; F Aung; S Kornblau; M A Fernandez Vina; R E Champlin; S O Ciurea
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

6.  Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors.

Authors:  J Girdlestone; M Isamat; D Gewert; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

Authors:  L T Peltenburg; R Dee; P I Schrier
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

8.  False homozygosity results in HLA genotyping due to loss of chromosome 6 in a patient with acute lymphoblastic leukemia.

Authors:  Hyewon Park; Jungwon Hyun; Sung Sup Park; Myoung Hee Park; Eun Young Song
Journal:  Korean J Lab Med       Date:  2011-10-03

Review 9.  Tumor evasion from T cell surveillance.

Authors:  Katrin Töpfer; Stefanie Kempe; Nadja Müller; Marc Schmitz; Michael Bachmann; Marc Cartellieri; Gabriele Schackert; Achim Temme
Journal:  J Biomed Biotechnol       Date:  2011-11-15

10.  Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix.

Authors:  Q Cheng; W M Lau; S H Chew; T H Ho; S K Tay; K M Hui
Journal:  Br J Cancer       Date:  2002-01-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.